InvestInfoAI
Rubric Capital Management LP

Q3 2025 · 13F-HR

Rubric Capital Management LPholdings as filed

Filed 2025-11-14 · accession 0001104659-25-112706

$8.86B
Reported value
72
Positions
2025-09-30
Period end
View analyzed profile →PRO

The Brief · Rubric Capital Management LP · Q3 2025

AI · grounded in 13F

Rubric Capital Management LP established a new position in Talen Energy Corp TLN valued at $1.53B. The fund also initiated new stakes in the SPDR S&P 500 ETF TR SPY for $932.65M and FTAI Aviation Ltd FTAI for $560.74M. Additional new positions include Teva Pharmaceutical Inds Ltd TEVA and iShares TR IWM.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
87422Q109TLNTALEN ENERGY CORP$1.53B17.3%3,602,171CommonSOLE
78462F103SPYSPDR S&P 500 ETF TR$932.7M10.5%1,400,000PUTSOLE
G3730V105FTAIFTAI AVIATION LTD$560.7M6.33%3,360,553CommonSOLE
881624209TEVATEVA PHARMACEUTICAL INDS LTD$497.9M5.62%24,650,000CommonSOLE
464287655IWMISHARES TR$483.9M5.46%2,000,000PUTSOLE
G9456A100GLNGGOLAR LNG LTD$370.9M4.19%9,178,978CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$302.6M3.41%20,000,000CommonSOLE
89346D107TACTRANSALTA CORP$218.0M2.46%15,948,451CommonSOLE
03969K108ARQTARCUTIS BIOTHERAPEUTICS INC$202.6M2.29%10,749,457CommonSOLE
343412102FLRFLUOR CORP NEW$189.3M2.14%4,500,000CommonSOLE
589400100MCYMERCURY GENL CORP NEW$174.2M1.97%2,054,504CommonSOLE
088929104BGCBGC GROUP INC$170.3M1.92%18,000,000CommonSOLE
G52694109KNSAKINIKSA PHARMACEUTICALS INTL$155.3M1.75%4,000,000CommonSOLE
92556V106VTRSVIATRIS INC$152.3M1.72%15,385,000CommonSOLE
219798105QDELQUIDELORTHO CORP$136.6M1.54%4,637,738CommonSOLE
03168L105AMRXAMNEAL PHARMACEUTICALS INC$123.5M1.39%12,334,941CommonSOLE
29415C101EOSEEOS ENERGY ENTERPRISES INC$117.3M1.32%10,300,000CommonSOLE
G7500M104RNWRENEW ENERGY GLOBAL PLC$111.2M1.25%14,438,061CommonSOLE
457985208IARTINTEGRA LIFESCIENCES HLDGS C$109.7M1.24%7,653,934CommonSOLE
80810D103SDGRSCHRODINGER INC$105.7M1.19%5,268,817CommonSOLE
19459J104COLLCOLLEGIUM PHARMACEUTICAL INC$98.9M1.12%2,826,498CommonSOLE
27923Q109ECVTECOVYST INC$91.1M1.03%10,400,000CommonSOLE
G61188101LBTYALIBERTY GLOBAL LTD$88.8M1.00%7,750,367CommonSOLE
M85548101SSYSSTRATASYS LTD$87.4M0.99%7,803,097CommonSOLE
24665A103DKDELEK US HLDGS INC NEW$86.7M0.98%2,687,449CommonSOLE
G9001E128LILAKLIBERTY LATIN AMERICA LTD$86.6M0.98%10,256,935CommonSOLE
071813109BAXBAXTER INTL INC$86.0M0.97%3,774,889CommonSOLE
194014502ENOVENOVIS CORPORATION$83.4M0.94%2,750,000CommonSOLE
98985Y108ZYMEZYMEWORKS INC$80.5M0.91%4,710,551CommonSOLE
89532M101TRVITREVI THERAPEUTICS INC$78.1M0.88%8,531,860CommonSOLE
G2143T103CMPRCIMPRESS PLC$74.4M0.84%1,180,789CommonSOLE
68375N103OPKOPKO HEALTH INC$74.1M0.84%47,791,243CommonSOLE
00676P107ADEAADEIA INC$72.0M0.81%4,284,205CommonSOLE
651229106NWLNEWELL BRANDS INC$68.1M0.77%13,000,000CommonSOLE
879433829TDSTELEPHONE & DATA SYS INC$62.8M0.71%1,600,000CommonSOLE
56400P706MNKDMANNKIND CORP$61.3M0.69%11,414,671CommonSOLE
36162J106GEOGEO GROUP INC NEW$61.2M0.69%2,986,915CommonSOLE
743713109PRLBPROTO LABS INC$56.2M0.63%1,123,338CommonSOLE
644393100NFENEW FORTRESS ENERGY INC$54.7M0.62%24,767,087CommonSOLE
68752M108OFIXORTHOFIX MED INC$54.5M0.61%3,721,715CommonSOLE
G61188127LBTYKLIBERTY GLOBAL LTD$53.3M0.60%4,538,570CommonSOLE
82835W108SPRYARS PHARMACEUTICALS INC$45.2M0.51%4,500,000CommonSOLE
808541106MATVMATIV HOLDINGS INC$45.0M0.51%3,982,442CommonSOLE
21871N101CXWCORECIVIC INC$39.9M0.45%1,961,446CommonSOLE
01626W101ALITALIGHT INC$37.2M0.42%11,398,583CommonSOLE
427746102HRTXHERON THERAPEUTICS INC$36.7M0.41%29,100,728CommonSOLE
589492107MREOMEREO BIOPHARMA GROUP PLC$31.5M0.36%15,307,347CommonSOLE
00182C103ANIPANI PHARMACEUTICALS INC$31.5M0.35%343,414CommonSOLE
G59665102MGTXMEIRAGTX HLDGS PLC$30.7M0.35%3,726,451CommonSOLE
810648105SCPHSCPHARMACEUTICALS INC$28.9M0.33%5,101,886CommonSOLE
868459108SUPNSUPERNUS PHARMACEUTICALS INC$28.5M0.32%595,366CommonSOLE
G4766E116INDVINDIVIOR PLC$27.3M0.31%1,130,961CommonSOLE
00404A109ACHCACADIA HEALTHCARE COMPANY IN$27.2M0.31%1,100,000CommonSOLE
98423J101XPERXPERI INC$26.9M0.30%4,143,744CommonSOLE
88162F105TTITETRA TECHNOLOGIES INC DEL$26.0M0.29%4,529,783CommonSOLE
13765N107CNNECANNAE HLDGS INC$24.2M0.27%1,319,589CommonSOLE
23954D109DAWNGBXDAY ONE BIOPHARMACEUTICALS I$23.8M0.27%3,377,071CommonSOLE
879512309TSATTELESAT CORP$22.4M0.25%843,781CommonSOLE
87615L107THTARGET HOSPITALITY CORP$18.6M0.21%2,189,456CommonSOLE
H11356104BGBUNGE GLOBAL SA$15.3M0.17%188,347CommonSOLE
G72800108PRTAPROTHENA CORP PLC$15.0M0.17%1,540,373CommonSOLE
29082K105EMBCEMBECTA CORP$14.6M0.17%1,037,416CommonSOLE
G9001E102LILALIBERTY LATIN AMERICA LTD$14.5M0.16%1,743,065CommonSOLE
812215200SEGSEAPORT ENTMT GROUP INC$13.0M0.15%568,530CommonSOLE
608190104MHKMOHAWK INDS INC$11.1M0.12%85,726CommonSOLE
03879J100ABUSARBUTUS BIOPHARMA CORP$7.2M0.08%1,575,376CommonSOLE
375916103GILGILDAN ACTIVEWEAR INC$4.9M0.05%84,252CommonSOLE
72815G108MYPSPLAYSTUDIOS INC$2.6M0.03%2,697,384CommonSOLE
68375NAG8OPK 3.75 01/15/29OPKO HEALTH INC$1.9M0.02%1,250,000CommonSOLE
27966L306EDSAEDESA BIOTECH INC$1.7M0.02%687,500CommonSOLE
89469A104THSTREEHOUSE FOODS INC$1.4M0.02%70,372CommonSOLE
88338N206TXMDTHERAPEUTICSMD INC$1.3M0.01%1,192,191CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.